Text
Industry
Sponsored by
The microbiological laboratory applying AI to specific analysis activities.
Topical treatment is achieving all endpoints for efficacy and safety in mild, moderate, and severe atopic dermatitis.
The findings of a recent study suggest that the gut microbiota contributes to improve metabolic health after gastric bypass surgery.
The collaboration will focus on various aspects of the human microbiome that could benefit new product development.
Depressed BD patients present significant alterations in the taxonomic compositions of their gut microbiota, and this may be related to inflammatory pathways and depression severity.
The findings of a recent study suggest that a mild gastrointestinal infection can alter gut commensal populations in ways that boost the commensal’s ability to proliferate during an infection.
The findings of a recent study imply that Fusobacterium nucleatum may play a causal role in worsening RA, offering potential therapeutic targets for effectively alleviating RA symptoms.
The highlights of the Postbiotics Discussion Panel that took place in Bratislava during IPC 2023.
The FDA has granted orphan drug designation for IBT’s product IBP-1016 for gastroschisis.
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x.
